US Patent 9856279 Therapeutically active compositions and their methods of use
Patent 9856279 was granted and assigned to Agios Pharmaceuticals on January, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 7 Dec, 2023
Golden AI
Edits made to:
Article (+200 characters)
Article
Patent abstract
Provided are piperazine compounds of Formula I useful for treating cancer and methods of treating cancer comprising administering to a subject in need thereof a compound described here.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Francesco G. Salituro0
Janeta Popovici-Muller0
Jeffrey O. Saunders0
Jeremy M. Travins0
Sheldon Cao0
Shunqi Yan0
Xuefei Tan0
Zhixiong Ye0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09856279 Therapeutically active compositions and their methods of use US Patent 9856279 Therapeutically active compositions and their methods of use
Infobox
Patent Number
09856279
Patent Number
9856279
Edits on 16 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09856279 Therapeutically active compositions and their methods of use
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09856279
Date of patent
January 2, 2018
Patent application number
15130358
Date Filed
April 15, 2016
Patent primary examiner
Find more entities like US Patent 9856279 Therapeutically active compositions and their methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.